Clinical risk factors and predictive value of inflammatory biomarkers for 2-year recurrence after standard surgery for endometrial cancer: a retrospective study among the Chinese population

Key Points

• This research aims to identify clinical risk factors and inflammatory biomarkers that predict recurrence after surgery for endometrial cancer.
• Retrospective analysis of endometrial cancer cases
• Examination of FIGO stage, tumor size, and inflammatory biomarkers
• Assessment of predictive models for recurrence risk
• Advanced FIGO stage strongly predicts recurrence
• Larger tumor size correlates with higher recurrence risk
• Elevated PIV and CRP levels are key indicators
• Reduced albumin levels are associated with increased recurrence